Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) is expected to release its Q1 2025 earnings data after the market closes on Monday, May 12th. Analysts expect the company to announce earnings of $0.20 per share and revenue of $321.21 million for the quarter.
Guardian Pharmacy Services Price Performance
Shares of GRDN stock opened at $25.61 on Friday. Guardian Pharmacy Services has a 12-month low of $14.16 and a 12-month high of $26.91. The firm has a 50-day moving average price of $22.13 and a 200 day moving average price of $21.56.
Analysts Set New Price Targets
Separately, Truist Financial boosted their target price on Guardian Pharmacy Services from $24.00 to $25.00 and gave the stock a “buy” rating in a report on Friday, April 11th.
Guardian Pharmacy Services Company Profile
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Read More
- Five stocks we like better than Guardian Pharmacy Services
- How to Use the MarketBeat Excel Dividend Calculator
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
- How to Short a Stock in 5 Easy Steps
- Here’s The Reason Goldman Sachs Is Bullish On MercadoLibre Stock
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Analyst-Favorite Bitcoin Miner CleanSpark: Worth the Hype?
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
